Clinical Trial Update: Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the efficacy and safety of Lornoxicam in patients with Acute Coronary Syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Lornoxicam (lornoxicam)

Snippet

Sponsor: Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED